Key Takeaways
- A poison pill, or shareholder rights plan, lets every shareholder except a would-be acquirer buy discounted stock once the acquirer crosses a set ownership threshold, diluting its stake.
- A board can adopt a pill by resolution in a matter of hours, so every public company can act as if it has one, and federal disclosure rules give early warning of a large buyer.
- Pills can be seen as protecting management's jobs or as giving the board leverage to negotiate a better price, and Delaware courts review them for whether they are a reasonable response to a real threat.
Few structures in mergers and acquisitions have a name as dramatic as the poison pill. What is it, and how can a single board resolution stop a would-be acquirer in its tracks?
In this TalksOnLaw Brief, John Morley, the Augustus E. Lines Professor of Law at Yale Law School, explains how poison pills work, how easily boards can adopt them, and the competing theories of why they exist.
How a Poison Pill Works
A poison pill, Professor Morley explains, is a mechanism that deters a potential acquirer from taking control of a target company. It is often called a shareholder rights plan because of how it operates: if someone buys more than a certain percentage of the company's stock without permission from the board, every other stockholder gets the right to buy a large amount of stock at a discounted price. The acquirer is left out, and its stake is diluted.
His example is Twitter. When Elon Musk began building a stake in 2022, Twitter's board adopted a pill that was worded generally but plainly had Musk in mind: if any person acquired more than 15% of the voting stock, the company would issue a large number of discounted shares to every other stockholder. Pills come in many shapes: sometimes shares are sold cheaply or given away, and some pills are triggered at a lower ownership level for buyers who intend to change control than for buyers who do not.
Adopted in Hours
All it takes to adopt a pill, Professor Morley notes, is a resolution of the board of directors. With a law firm's template, a board can have a pill in place within hours. As a practical matter, that means every company can operate as if it has a poison pill, whether or not it actually does. Federal securities law makes this even easier, because anyone who acquires more than 5% of a company's shares must disclose that stake soon after crossing the threshold. A company usually learns there is “a shark swimming in the waters” well before it needs a pill.
Why Pills Exist
Professor Morley offers a more cynical and a less cynical view. The cynical theory is that directors and senior managers want to keep their jobs, knowing they will be fired if a hostile takeover succeeds. The less cynical view is that a pill gives the company time and leverage to negotiate. If an acquirer could gain control just by buying shares at the prevailing market price, the company would have no good way to extract a premium reflecting the full value of control. He adds that people other than stockholders, such as workers who moved to be near their jobs or built skills specific to the firm, have made investments in the company that may deserve protection too.
What to Know Now
The poison pill remains a staple of takeover defense. Delaware courts have upheld rights plans since Moran v. Household International (1985), reviewing them under the enhanced scrutiny of Unocal Corp. v. Mesa Petroleum, which asks whether a defensive measure is a reasonable and proportionate response to a real threat. Courts also set limits: in the Williams Companies litigation, Delaware courts struck down a pill with a 5% trigger adopted against generalized activist concerns. The early warning Professor Morley describes has also tightened, as SEC amendments adopted in 2023 shortened the deadline for an initial Schedule 13D filing to five business days after crossing 5%. In the Twitter fight, Musk ultimately acquired the company through a merger agreement approved by its board.
